STOCK TITAN

Marex Group: Paolo Tonucci sells 16,668 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Marex Group Ltd (MRX) officer Paolo Tonucci, identified as Chief Strategist and CEO, Capital Markets, sold 16,668 ordinary shares on November 9, 2026. The three reported lots were 3,196 shares at a weighted average $67.8914 per share, 10,760 at $68.7356, and 2,712 at $69.4058. The sales were made under a Rule 10b5-1 plan entered into on October 22, 2025.

Insider Tonucci Paolo
Role See Remarks
Sold 16,668 shs ($1.14M)
Share of Position Sold 1.3%
Type Security Shares Price Value
Sale Ordinary Shares F1, F2 3,196 $67.8914 $217K
Sale Ordinary Shares F1, F3 10,760 $68.7356 $740K
Sale Ordinary Shares F1, F4, F5 2,712 $69.4058 $188K
Holdings After Transaction: Ordinary Shares — 1,236,237 shares (Direct)
Holdings Before and After: Ordinary Shares, 1,252,905 to 1,236,237 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (5)
  1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.175 to $68.1625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.1775 to $69.1725, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.175 to $69.885, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The number of ordinary shares reported herein includes 220,746 shares underlying unvested deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Ordinary shares sold 16,668 shares Three reported transactions on November 9, 2026
Shares sold 3,196 shares November 9, 2026 transaction; weighted average price $67.8914 per share
Weighted average sale price $67.8914 per share 3,196 shares sold on November 9, 2026
Shares sold 10,760 shares November 9, 2026 transaction; weighted average price $68.7356 per share
Weighted average sale price $68.7356 per share 10,760 shares sold on November 9, 2026
Shares sold 2,712 shares November 9, 2026 transaction; weighted average price $69.4058 per share
Weighted average sale price $69.4058 per share 2,712 shares sold on November 9, 2026
Rule 10b5-1 plan regulatory
"sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MRX shares did Paolo Tonucci sell, and at what prices?

Paolo Tonucci, an officer of Marex Group Ltd, sold 16,668 ordinary shares on November 9, 2026, in three lots: 3,196 at a weighted average $67.8914 per share, 10,760 at $68.7356, and 2,712 at $69.4058. The sales were made under a Rule 10b5-1 plan entered into on October 22, 2025.

What price ranges were reported for Paolo Tonucci’s MRX share sales?

For the 3,196-share lot, prices ranged from $67.175 to $68.1625; for 10,760 shares, from $68.1775 to $69.1725; and for 2,712 shares, from $69.175 to $69.885. The reported per-share prices are weighted averages for the respective lots.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tonucci Paolo

(Last)(First)(Middle)
C/O MAREX GROUP LIMITED, 155 BISHOPSGATE

(Street)
LONDONEC2M 3TQ

(City)(State)(Zip)

UNITED KINGDOM

(Country)
2. Issuer Name and Ticker or Trading Symbol
Marex Group Ltd [ MRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares11/09/2026S(1)3,196D$67.8914(2)1,249,709D
Ordinary Shares11/09/2026S(1)10,760D$68.7356(3)1,238,949D
Ordinary Shares11/09/2026S(1)2,712D$69.4058(4)1,236,237(5)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
2. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.175 to $68.1625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.1775 to $69.1725, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.175 to $69.885, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The number of ordinary shares reported herein includes 220,746 shares underlying unvested deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Remarks:
Chief Strategist and CEO, Capital Markets
/s/ Scott Linsley as Attorney-in-Fact, for Paolo Tonucci11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading